Prevalence of Major outcome changes in scientific trials registered on ClinicalTrials.gov: a cross‐sectional review. F1000Res The anti‐inflammatory outcomes of PEA appear to be mainly associated with its capacity to modulate mast cell activation and degranulation, and this action is also referred to as the ALIA (autacoid regional inflammation antagonism) https://johna680tle5.wikitron.com/user